[1]
B. Elewski, M. Zirwas, A. Kurbasic, S. Schneider, A. Claxton, and J. Silverberg, “Efficacy and Safety of Tralokinumab in US Adults with Moderate-to-Severe Atopic Dermatitis: A Post-hoc Analysis of ECZTRA3”, J of Skin, vol. 7, no. 2, pp. 686–695, Mar. 2023.